Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03149874Completed
Randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Benha University. Primary endpoints: Hepatitis B virus Seroprotection after one month and Hepatitis B virus Seroprotection after three months. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03149874.